EMBL Technology Fund sold all its shares in vasopharm GmbH

HeidelbergCapital Private Equity, EF Investments S.à.r.l. (Entrepreneuers Fund), Bayern Kapital, Hanseatic Asset Management LBG, Dr. Andrew Clark acquired all shares of EMBL Technology Fund in Vasopharm GmbH.

P+P partner Dr. Michael Inhester advised the investors, supported by associate Eckhardt Weber.